GRCE

GRACE THERAPEUTICS, INC.

GRCE · CIK 1444192 · Annual (10-K) · Last 6 years

Financial Trends

Revenue
20202025
Net Income−$10M
20202025
Operating CF−$15M
20202025
Free Cash Flow
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue——$0.1B———
Cost of Revenue———$0.0B$0.0B—
Gross Profit——————
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense——————
Operating Income$-0.0B$-0.0B$-0.1B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-0.79$-1.35$-0.95———
EPS (Diluted)$-0.79$-1.35$-0.95———

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.0B$0.0B$0.0B$-0.0B$-0.0B$0.0B
Capital Expenditures—————$0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B
← Companies